Secondary prevention for patients after a myocardial infarction: summary of updated NICE guidance.
Royal College of Physicians, National Clinical Guideline Centre, London NW1 4LE, UK.
Katie
K
Jones
Leanne
L
Saxon
William
W
Cunningham
Phil
P
Adams
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D006801:Humans; D009203:Myocardial Infarction / Q000517:prevention & control* / Q000534:rehabilitation / Q000628:therapy; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D040242:Risk Reduction Behavior; D055502:Secondary Prevention
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D010975:Platelet Aggregation Inhibitors